SYSTOPIC LABORATORIES PVT. LTD.-COMPANY INSIGHT - TF Market Research

SYSTOPIC LABORATORIES PVT. LTD.-COMPANY INSIGHT

18 pages — Published Dec 11, 2008
Price $26,910.00  |  Buy this Report Now
  
This report is also available for purchase on a per-page basis.

About This Report

  
Brief Excerpt:
...###, Pragati Chamber, Commercial Complex, Ranjit nagar, New Delhi ######, India email: systopic@systopic.com Website: http://www.systopic.com phone: ##-##-######## ...
  
Source:
LIFE SCIENCE ANALYTICS
Author:
HARINATHA, G.
Company
SYSTOPIC LABORATORIES PVT LTD
Geographic Regions
ASIA , INDIA , SOUTHERN ASIA
Format:
PDF Adobe Acrobat
Sections
TitleStarting PageNumber of Pages
Company Information11
Systopic Laboratories Pvt. ltd. [NonUS -- Symbol : Private]11
Formation Date: 198211
Business Summary11
Product Glance31
Trial Phase31
No of Products31
Diseasehub Classification31
Disease Hub31
Product Summary41
Products42
Condition Treated42
Trial Phase Source Partner42
Product Details51
1. Amcard Disease Hub Description51
Therapeutic Indication Drug Class51
Current Trial Trial Details Last Updated 2. Amcard LP Disease Hub Description61
Therapeutic Indication Drug Class Current Trial Trial Details Last Updated 3. Amcard AT Disease Hub Description61
Therapeutic Indication Drug Class Current Trial Trial Details Last Updated 4. Giftan Disease Hub Description61
Therapeutic Indication Drug Class Current Trial Trial Details Last Updated 5. Giftan HC Disease Hub Description61
Therapeutic Indication Drug Class Current Trial Trial Details Last Updated 6. Amace Disease Hub Description61
Therapeutic Indication Drug Class Current Trial Trial Details Last Updated 7. Amace BP Disease Hub Description71
Therapeutic Indication Drug Class Current Trial Trial Details Last Updated 8. Orvas Disease Hub Description71
Therapeutic Indication Drug Class Current Trial Trial Details Last Updated 9. Piosys Disease Hub Description71
Therapeutic Indication Drug Class Current Trial Trial Details Last Updated 10. Pio M Disease Hub Description71
Therapeutic Indication71
Drug Class Current Trial Trial Details Last Updated 11. Isryl Disease Hub Description81
Therapeutic Indication Drug Class Current Trial Trial Details Last Updated 12. ME12 Disease Hub Description81
Therapeutic Indication Current Trial Trial Details Last Updated 13. ME plus Disease Hub Description81
Therapeutic Indication Current Trial Trial Details Last Updated 14. Osicare Disease Hub Description81
Therapeutic Indication Current Trial Trial Details Last Updated 15. Topnac-P Disease Hub Description81
Therapeutic Indication Drug Class Current Trial Trial Details81
Last Updated 16. Systaflam Disease Hub Description91
Therapeutic Indication Current Trial M Trial Details Last Updated 17. Kineto forte Disease Hub Description91
Therapeutic Indication Drug Class Current Trial Trial Details Last Updated 18. Kineto DP Disease Hub Description91
Therapeutic Indication Drug Class Current Trial Trial Details Last Updated 19. Kineto D Disease Hub Description91
Therapeutic Indication Drug Class Current Trial Trial Details Last Updated91
20. Nac Disease Hub Description101
Therapeutic Indication Drug Class Current Trial Trial Details Last Updated 21. Nac plus Disease Hub Description101
Therapeutic Indication Drug Class Current Trial Trial Details Last Updated 22. Nac 50 Disease Hub Description101
Therapeutic Indication Drug Class Current Trial Trial Details Last Updated 23. AF Disease Hub Description101
Therapeutic Indication Drug Class Current Trial Trial Details Last Updated 24. AF-kit Disease Hub Description101
Therapeutic Indication Current Trial Trial Details Last Updated 25. Terbest Disease Hub Description111
Therapeutic Indication Drug Class Current Trial Trial Details Last Updated 26. Levosiz Disease Hub Description111
Therapeutic Indication Drug Class Current Trial Trial Details Last Updated 27. Sizon Disease Hub Description111
Therapeutic Indication Drug Class Current Trial Trial Details Last Updated 28. Topinate Disease Hub Description111
Therapeutic Indication Drug Class Current Trial Trial Details Last Updated 29. Saltopic Disease Hub Description111
Therapeutic Indication Current Trial M Trial Details Last Updated 30. Acnesol CL Disease Hub Description121
Therapeutic Indication Drug Class Current Trial Trial Details Last Updated 31. Acnesone Disease Hub Description121
Therapeutic Indication Current Trial Trial Details Last Updated 32. Rextop Disease Hub Description121
Therapeutic Indication Current Trial Trial Details Last Updated 33. Flutopic Disease Hub Description121
Therapeutic Indication Current Trial Trial Details Last Updated 34. Nidagen Disease Hub Description121
Therapeutic Indication Current Trial Trial Details121
Last Updated 35. Nidagest Disease Hub Description131
Therapeutic Indication Current Trial Trial Details Last Updated 36. Etosys Disease Hub Description131
Therapeutic Indication Current Trial Trial Details Last Updated 37. Etosys MF Disease Hub Description131
Therapeutic Indication Current Trial Trial Details Last Updated 38. Sysfol Disease Hub Description131
Therapeutic Indication Current Trial Trial Details Last Updated 39. Normaxin Disease Hub Description131
Therapeutic Indication131
Current Trial Trial Details Last Updated 40. Cyra Disease Hub Description141
Therapeutic Indication Drug Class Current Trial Trial Details Last Updated 41. Tacko M Disease Hub Description141
Therapeutic Indication Drug Class Current Trial Trial Details Last Updated 42. Tackodom Disease Hub Description141
Therapeutic Indication Current Trial Trial Details Last Updated 43. Analiv Disease Hub Description141
Therapeutic Indication Current Trial Trial Details Last Updated 44. Analiv 500 Disease Hub Description141
Therapeutic Indication Current Trial M Trial Details Last Updated 45. Systavit- AZ Disease Hub Description151
Therapeutic Indication Current Trial M Trial Details Last Updated 46. Asmatide- BR Disease Hub Description151
Therapeutic Indication Current Trial Trial Details Last Updated 47. In SR Disease Hub Description151
Therapeutic Indication Drug Class Current Trial Trial Details Last Updated 48. Syspride Disease Hub Description151
Therapeutic Indication Current Trial M Trial Details Last Updated 49. Syspride MPS Disease Hub Description151
Therapeutic Indication151
Current Trial M Trial Details Last Updated 50. Mosys MPS Disease Hub Description161
Therapeutic Indication Current Trial Trial Details Last Updated 51. Lipicon-S Disease Hub Description161
Therapeutic Indication Drug Class Current Trial Trial Details Last Updated 52. Topisal Disease Hub Description161
Therapeutic Indication Current Trial Trial Details Last Updated 53. Topnac Disease Hub Description161
Therapeutic Indication Drug Class Current Trial Trial Details Last Updated 54. Alan Disease Hub Description161
Therapeutic161
Indication Current Trial Trial Details Last Updated 55. Sysron-N Disease Hub Description171
Therapeutic Indication Current Trial Trial Details Last Updated 56. Atpic Disease Hub Description171
Therapeutic Indication Drug Class Current Trial M Trial Details Last Updated 57. Normospas-DP Disease Hub Description171
Therapeutic Indication Current Trial Trial Details Last Updated 58. Sysnide Disease Hub Description171
Therapeutic Indication Current Trial Trial Details171
Last Updated172

Table Of Contents

TF Market Research® reports contain in-depth primary research and statistics, market trends, forecasts, segment analysis and much more from over 100 top consulting, market research and business publishing sources. The service is updated daily.

About the Author


Cite this Report

  
MLA:
TF Market Research. "SYSTOPIC LABORATORIES PVT. LTD.-COMPANY INSIGHT" Dec 11, 2008. Alacra Store. May 18, 2013. <http://www.alacrastore.com/storecontent/markintel/LIFE_SCIENCE_ANALYTICS-50254575>
  
APA:
TF Market Research. (2008). SYSTOPIC LABORATORIES PVT. LTD.-COMPANY INSIGHT Dec 11, 2008. New York, NY: Alacra Store. Retrieved May 18, 2013 from <http://www.alacrastore.com/storecontent/markintel/LIFE_SCIENCE_ANALYTICS-50254575>
  
$26,910.00
$  £  €
Have a Question?
Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.
More Research
Search all our Market Research from one place.